Using EEG to time stopping caffeine in premature infants
Official title: The Role of Electroencephalography Evaluation in Caffeine Discontinuation Timing in Premature Infants
Run by Uludag University · NCT07324941 · Data updated 2026-11-12
This study will see if EEG brain recordings can help doctors decide when to stop caffeine treatment in preterm infants so apnea does not come back.
Quick facts
| Study type | Observational |
|---|---|
| Ages | Any age to 1 Month |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Uludag University Academic / other |
| Locations | 1 site (Bursa) |
| Status | Recruiting |
| Started | January 2, 2026 |
| Main results expected | January 2, 2027 |
| Study ends | January 2, 2027 |
| Registry record updated | May 1, 2026 |
| Trial ID | NCT07324941 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Eligible infants are those born preterm who received prophylactic or therapeutic caffeine (including infants <28 weeks or those <32 weeks who required invasive ventilation) and whose parents consent to EEG recording.
✕Probably not a fit
Infants with major congenital anomalies, those who cannot undergo EEG, those who never received caffeine, or those transferred around the discontinuation period are unlikely to benefit from the study findings.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational study of premature infants treated with caffeine for apnea of prematurity. At the planned point of stopping caffeine, infants will have an electroencephalogram (EEG) to measure functional brain maturation. Researchers will compare EEG findings with whether apnea recurs after caffeine is discontinued. No experimental treatments are given and standard clinical care continues while data are collected at a single neonatal intensive care unit.
Why it matters
Potential benefit: If successful, using EEG to guide when to stop caffeine could reduce apnea recurrences and avoid unnecessary prolonged caffeine exposure and hospital stays.
How similar studies have gone: Using EEG to time caffeine discontinuation is relatively novel with only limited prior data and no large, definitive studies demonstrating clear success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Infants born before 28 weeks of gestation with a birth weight of 1250 grams or less, who received prophylactic caffeine therapy. 2. Infants with a birth weight greater than 1250 grams and a gestational age below 32 weeks, who required invasive mechanical ventilation and were started on prophylactic caffeine therapy. 3. Infants born at less than 37 weeks of gestation, admitted to the neonatal intensive care unit, and treated with caffeine for apnea of prematurity. 4. Infants whose parents or legal guardians provided informed consent. Exclusion Criteria: 1. Infants who did not receive caffeine therapy, 2. Infants for whom an EEG could not be performed, 3. Infants with major congenital malformations such as neuromuscular disorders, central nervous system developmental abnormalities, thoracic malformations, or major cardiac anomalies, 4. Infants who were transferred to another facility within one week before or after discontinuation of caffeine therapy.
Where it's running
-
Division of Neonatology, Department of Pediatrics, Bursa Uludağ University Faculty of Medicine
Bursa, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Salih Çağrı Çakır
- Email: salihcagri@uludag.edu.tr
- Phone: +90 533 3453739
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Wireless MicroPremVitals Button Sensor for the NICU
This study tests a tiny wireless sensor system to monitor heart rate, oxygen, and temperature in extremely preterm babies in the NICU to see if it works safely without wires.
-
Caffeine in pregnancy: how the mother and baby handle it during delivery
This study tests how caffeine is processed in pregnant people and how much reaches the baby when given shortly before delivery.
-
Detection of Respiratory Events in Extremely Preterm Infants Using Acoustic Monitoring
A new acoustic monitoring approach is being tested to detect breathing problems in very preterm babies to help NICU teams spot and manage apnea and related events.
-
PIMUN to reduce low-oxygen episodes in preterm infants
We will test whether PIMUN, a soft garment that gives gentle pulsatile dorsal stimulation, can reduce low-oxygen (SpO2 <90%) episodes in preterm infants born at 24–34 weeks who have apnea of prematurity.
-
Predicting and stopping breathing pauses in very preterm babies with gentle vibration
This study tests a vibro-tactile device to see if it can predict and prevent apnea with bradycardia in preterm infants by briefly stimulating them during episodes.
-
T-piece versus ventilator breathing support at birth for extremely premature babies
This will test whether using a ventilator to give precise nasal positive-pressure breaths at birth helps extremely premature infants (25–28 weeks) breathe better than the standard manual T‑piece resuscitator.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.